Hans Schikan brings more than 25 years of development, commercial and leadership experience in the (bio)pharmaceutical sector, latest as CEO of Prosensa in The Netherlands, a company focusing on rare diseases, with a lead program in Duchenne Muscular Dystrophy. During Mr. Schikan’s leadership, Prosensa established a collaboration with GlaxoSmithKline in 2009 and was listed on NASDAQ in a successful IPO in June 2013. The company was acquired by BioMarin early 2015 for up to USD 840 million. Mr. Schikan’s previous assignments include Vice President, Marketing and Strategic Development for the rare disease portfolio of Genzyme (acquired by Sanofi) and several senior commercial roles in Organon (acquired by Schering Plough, which in turn was acquired by Merck). He is currently on the board of a number of public and private biotech companies in The Netherlands, Belgium, Sweden and Switzerland. In addition he advises two Venture Capital funds. Finally, he is Chairman a.i. of the Dutch Top Sector for Life Sciences and Health.
Hans GCP Schikan
Join the community of BDP Life Sciences of Business Development professionals and Business leaders in Life Sciences & Health. Through our programmes you will connect with fellow participants, our speakers, coaches and alumni. Also connect with us online via LinkedIn.
Contribute to the development of future business leaders in Life Sciences & Health by becoming a speaker, mentor or sponsor of our programmes. Contact us to discuss the possibilities via info[at]bdplifesciences.com.
RECRUIT BD TALENT
Are you looking for a Business Development professional? Our partner PRIMER BioBusiness is specialised in the recruitment of commercial talent for the Life Sciences. Whether you need new talent, experienced professional ar an executive to lead your company, contact us to start your search.